Trial NCT03493568

View at ClinicalTrials.gov 
Org. Study IDs: Be-OnE Study

Last trial update was posted on 2024-02-09

MeSH Interventions

Dolutegravir Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

MeSH Conditions


Other Conditions

HIV-1-infection

Stopping Reasons

The futility analysis on 24-week results estimated that there was only 2% probability of verifying the study hypothesis of a higher proportion pat. with no residual viremia through 48w in arm E/C/F/TAF

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID